Kathleen Uhl, Acting Director of the Office of Generic Drugs in the Department of Health and Human Services (HHS) Center for Drug Evaluation and Research announced the policy shift, stating that the FDA would lift the restrictions on generic competitors of Plan B One Step effective immediately. Although generic pills will have a label indicating the medicine is intended for people 17 and older, ID is no longer a requirement for access.